Infection with the free-living amoeba Naegleria fowleri leads to life-threatening primary 38 amoebic meningoencephalitis. Efficacious treatment options for these infections are limited 39 and the mortality rate is very high (~98%). Parasite metabolism may provide suitable 40 targets for therapeutic design. Like most other organisms, glucose metabolism is critical for 41 parasite viability, being required for growth in culture. The genome of the parasite encodes 42 a single glucose phosphorylating enzyme, a glucokinase (Glck). The products of this 43 enzyme are required for both glycolysis and the pentose phosphate pathway. The N. 44
INTRODUCTION 60
Human infection by the free-living amoeba Naegleria fowleri can lead to life-threatening 61 illness. When trophozoites encountered in freshwater are inadvertently introduced into the 62 nasal passages, parasites can travel to the brain and cause a deadly infection, primary 63 amoebic meningoencephalitis (PAM). Between 1962 and 2016, 143 PAM cases have been 64 reported in the United States (Centers for Disease Control and Prevention). While the 65 frequency of reported infection is low, the limited treatment options have historically yielded 66 poor outcomes, with a study of 123 cases in the US revealing that 122 infections resulted in 67 fatalities (1). A combination therapy that included amphotericin B, miconazole, fluconazole, 68
and ketoconazole was used to successfully treat a single case of PAM, though the 69 contribution of this therapeutic cocktail to patient survival is unclear (2). More recently, 70 miltefosine has shown some promise as an anti-amoebic agent (3). Nevertheless, the lack 71 of effective therapies for this infection, which remains lethal in ~99% of cases, makes 72 elucidating therapeutic targets for novel drug discovery a high priority. 73
Mechanisms that the amoebae use to satisfy their metabolic needs are poorly 74 resolved and are primarily based on assessment of growth under different culturing 75 conditions and on analysis of the predicted gene content of the genome. The only N. 76 fowleri metabolic enzyme characterized to date, phosphofructokinase (PFK), is a 77 pyrophosphate-dependent (instead of ATP-dependent) enzyme (4). Use of the alternative 78 phosphoryl group donor is usually associated with enzymes from anaerobic organisms, 79
suggesting that N. fowleri may inhabit niches where oxidative phosphorylation is limited. 80
The role of glycolysis in meeting the metabolic needs of N. fowleri during human 81 infection remains unresolved. However, the relative abundance of glucose in both the brain 82 and cerebral-spinal fluid (CSF), and the correlation of parasite presence with reduced CSF 83 glucose concentrations, suggest that glucose depletion in the brain may be a consequence 84 of pathogen consumption (5) . Therefore, the carbon source may be important for parasite 85 metabolism. 86
Most eukaryotic cells rely on a hexose phosphotransferase (a hexokinase, HK) to 87 catalyze the first enzymatic step common to both the glycolytic and the pentose phosphate 88 pathways (PPP) to generate glucose-6-phophate (G6P). These enzymes typically have a 89 broad affinity for different hexoses, including glucose, mannose, fructose, and galactose. 90 N. fowleri harbors a single copy gene that encodes a predicted glucokinase (NfGlck) and 91 lacks other recognizable enzymes that could catalyze the transfer of the g-phosphoryl group 92 of ATP to glucose to generate G6P. Glucokinases (Glck), which are typically restricted to 93 using glucose as a substrate, have been classified into two groups, A and B (6). Group A 94
Glcks include enzymes found in Gram-negative bacteria, Cyanobacteria, and 95 amitochondriate protists. Group B Glck members include enzymes from Gram-positive 96 bacteria that can use either ATP or polyphosphate as a phosphoryl group donor. Here, we 97 describe the biochemical and structural characterization of NfGlck. This work has revealed 98 that the enzyme has a limited hexose substrate use (like other Glcks) and shares structural 99 similarity with the group A Glck from Trypanosoma cruzi (7). However, kinetic differences 100 suggest the NfGlck may have evolved to satisfy the metabolic needs of Naegleria in low 101 resource environments. Last, we describe the interrogation of a selected panel of potential 102 inhibitors which has yielded the first NfGlck inhibitors disclosed to date. These compounds 103 serve as a source of potential hits for further lead and therapeutic development. 104 105 heterologous expression and purification of a HK from the African trypanosome. Briefly, a 135 8 mL bacterial culture of E. coli M15(pREP4) harboring pQE30-NfGlck was used to 136 inoculate a 4 L culture which was grown to an OD600 of ~0.6 and then induced for 24 h at 137 room temperature with 500 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) and purified 138 using an approach modified from (8) Kyle, the University of Georgia) and cloned into the expression vector pBG1861 using ligand-162 independent cloning (9). The expression vector provides a non-cleavable N-terminal His6-tag 163 (SSGCID target ID NafoA.19900.a, SSGCID construct ID NafoA.19900.a.B11, SSGCID 164 batch NafoA.19900.a.B11.PW38443). NfGlck was expressed in E. coli Rosetta 165 BL21(DE3)R3 following standard SSGCID protocols as described previously (10). 166
Purification was done using Ni-NTA affinity and size exclusion chromatography following 167 standard SSGCID protocols (11). The purified protein was concentrated to 13.78 mg/mL in 168 its final buffer (25mM HEPES pH 7.0, 500mM NaCl, 5% glycerol, 2mM DTT, 0.025% NaN3), 169 flash frozen in liquid nitrogen and stored at -80°C. VariMax optics and a Saturn 944+ detector, using CuKa X-rays. The diffraction data were 185 reduced with the XDS package (12), and are summarized in Table 1 . 186
The structure was solved using the program MorDa (13) from the CCP4 package (14) . 187
The initial model was refined and extended using the phenix.ligand_pipeline script within 188 Phenix (15). Manual model building was done with Coot (16) and the structure was refined 189 in reciprocal space with Phenix.refine (15). Ligand restraints for AMPPNP and b-D-glucose 190 were generated using the Grade web server (http://grade.globalphasing.org). The structure 191 was validated using the built-in validation tools within Phenix. The coordinates and structure 192 factors were deposited in the PDB with accession codes 6DA0. 193 194 RESULTS 195 9 The dietary requirements of the free-living amoeba Naegleria fowleri are poorly defined, 196 with parasite growth described from cultures maintained in the presence of bacteria or 197 human feeder cells. Axenic culture in defined media has also been established (17), but 198 the role of individual components in the metabolic success of the parasites has not been 199 fully explored. 200
Most of the described media includes glucose. To assess the importance of this 201 carbon source to the parasite, trophozoites were seeded into standard NCM with or without 202 glucose ( Fig.1A ). After two days, culture in the absence of glucose led to reduced growth 203 and enhanced encystation. These cultures began to encyst earlier than cells cultured in 204 the presence of glucose and as a consequence failed to reach the density of cells under 205 standard conditions. To further consider the importance of glucose to the parasites, 206 trophozoites were incubated with the glycolytic poison 3-bromopyruvate (3BP) in standard 207 glucose-bearing (9 mM glucose) medium. Inclusion of the compound, which is known to 208 inhibit the glycolytic enzyme glyceraldehyde-3-phospate dehydrogenase (GAPDH) (18) led 209 to reduced cell growth ( Fig. 1B) , with only cysts detectable after two days of incubation. 210
The absence of glucose or treatment with 3BP could be impacting N. fowleri by 211 interfering with metabolism (through glycolysis) or sugar nucleotide biosynthesis (through 212 the pentose phosphate pathway). Entry into either of these pathways requires glucose-6-213 phosphate, which is typically generated by HK or Glck enzymes, suggesting inhibitors of 214 this activity could be useful anti-amoebic compounds. The N. fowleri genome does not 215 encode obvious HK-like enzymes but does harbor a single gene for a putative Glck. Unlike 216
HKs, which can transfer a phosphoryl group to different hexoses, Glcks have a restricted 217 substrate range, primarily utilizing glucose as an acceptor for the g-phosphoryl of ATP. 218
Beyond Glcks from other Naegleria spp. and related amoebae, NfGlck shares limited 219 identity (37%) with the Glck from Trichomonas vaginalis, a protist that lives primarily under 220 anaerobic conditions. The enzyme was less similar to HsGlck, T. cruzi Glck (TcGlck), and 221
Leishmania donovani Glck, with sequence identities of 25%, 27%, and 26%, respectively. 222
Recombinant NfGlck, which was purified to ~99% homogeneity (as determined by 223
Coomassie staining of an SDS-PAGE gel), was determined to be a monomer by gel 224 filtration chromatography. The enzyme displayed Michaelis-Menten kinetics when glucose 225 levels were increased ( Fig. 2A ) and had an apparent Km value of 42.5 ± 7.3 µM for the 226 sugar, a kcat value of 36.5 sec -1 , and a pH optimum of 8.5 (Fig. 2C ). NfGlck had a limited 227 number of sugar substrates it could use in catalysis, with detectable activity when glucose, 228 glucosamine, or fructose (at high concentration) were used as sugar substrates (Fig. 3A) . 229
Glucosamine was also a competitive inhibitor of glucose, with a Ki of 186.4 ± 20.6 µM. The 230 enzyme had an apparent Km value of 141.6 ± 9.9 µM for ATP ( Fig. 2B) . While AMP and 231 This protein is also the source of the closest structural homologs in the PDB, which are 240 structures of the TcGlck in complex with b-D-glucose and ADP (PDB code 2Q2R, 1.7Å 241 RMSD), in complex with CBZ-GLCN (5BRE, 1.8Å RMSD), in complex with BENZ-GLCN 242 (5BRD, 2.0Å RMSD), HPOP-GLCN (5BRF, 2.0Å RMSD), and DBT-GLCN (5BRH, 2.0Å 243 RMSD) (19) . The structure of HsGlck (3FGU) superimposes with an RMSD of 3.0Å. In 244 each of the alignments, ~300 out of the 370-380 residues were aligned. Structure solution 245
was facilitated by the domain approach of MorDa (13), which placed three domains from 246 PDB entries 5BRH, 1SZ2 and 3AAB with an overall RMSD of 1.2Å for 282 aligned Ca 247 atoms. HsGlck shares little sequence homology with NfGlck. The closest structural 248 homolog is HsGlck in complex with an allosteric inhibitor (4MLH), with an RMSD of 2.9Å 249 over 244 residues. While NfGlck and HsGlck share a similar fold and glucose binding 250 domain, the noted sequence and structural diversity between the two enzymes suggests 251 that specific inhibitors of NfGlck could be developed. 252
The structure of NfGlck was refined against diffraction data up to 2.2Å resolution 253 ( Fig. 4) . The structure refines with appropriate quality indicators (Table 1) and NfGlck 254 crystallizes with one molecule per asymmetric unit. N-terminal residues Met1-Glu23, and C-255 terminal residues Gly401-Lys443 do not have the sufficient electron density needed to be 256 modeled, while a consecutive model could be built for residues Pro23-Leu400. NfGlck 257 consists of two domains, a small a/b domain (residues N-Asn171 and Asn384-C) and a 258 larger a/b domain (His174-Glu382). NfGlck was crystallized in the presence of AMPPNP 259 and D-glucose and both molecules could be modeled with confidence, even though 260 AMPPNP did not appear to be fully occupied (81% refined occupancy). While D-glucose is 261 located at the domain interface, AMPPNP mostly binds to the large domain. the glucose binding is a blend of the NfGlck and the TcGlck binding mode: There is no 275 direct replacement for the interaction of His231 (Fig. 5D ). However, in HsGlck Thr168 has a 276 similar role as Thr127 in NfGlck. 277
Additional TcGlck structures have been described in the presence of several 278 glucosamine analogue inhibitors (Fig. 5C ). While the glucose moiety of the ligand binds 279 identically to glucose, the region that the substituent of the ligands occupies in TcGlck is 280 significantly different in NfGlck. Most notably, Phe339 in TcGlck is Trp370 in NfGlck which 281 would provide a steric hindrance for the ligands. Phe337, which provides a significant 282 hydrophobic interaction in TcGlck is His369 in NfGlck. It would require a conformational 283 change in NfGlck compared with the presented crystal structure for His369 to engage in 284 this hydrophobic interaction. In TcGlck, neither Phe337 nor Phe339 shows very distinct 285 conformational differences between the ADP/Glucose and the glucosamine analogues 286 structures. By extension, these two residues are expected to provide a very different 287 binding profile of glucosamine analogue inhibitors for NfGlck and TcGlck. 288 289 Identification of small molecule inhibitors of NfGlck. To identify inhibitors of NfGlck, a 290 subset of known HK inhibitors and related structural analogs were tested against the N. 291 fowleri glucokinase enzyme. For example, the screening collection assessed for this effort 292 contained compounds selected from the Pathogen Box chemical library that were known to 293 inhibit T. brucei hexokinase 1 (TbHK1), other structurally distinct small molecule inhibitors 294 identified in our TbHK1-based HTS campaigns, and analogs subsequently developed from 295 these hits (20) . The advantage of using these compounds included the likelihood of 296 inhibition of a related parasitic metabolic enzyme and, due to our past experiences with 297 validating these compounds, pre-existing data that showed (a) that these agents did not 298 interfere with the coupled enzyme used in the screen and (b) that the compounds were 299 generally non-toxic to mammalian cells (MMV, (20)). 300
NfGlck was inhibited by two structurally-related bis-guanadinyl compounds from the 301 Pathogen Box collection, MMV688179 and MMV68827, which had anti-parasitic activity 302 against African trypanosomes (21). Interestingly, MMV688179 yielded an IC50 value of 2.02 303 ± 0.31 µM against NfGlck and was similarly active against TbHK1 and PfHK with IC50 304 values of 2.90 ± 1.13, and 0.78 ± 0.17 µM, respectively. This compound, which was a 305 mixed inhibitor with respect to ATP, did not inhibit HsGlck at 10 µM (Table 2) . 306
Comparatively, the related compound MMV688271 was a mixed inhibitor with respect to 307 ATP and showed modestly more potent inhibition of parasite enzymes with IC50 values at 308 least 2-fold better than MMV688179. However, the two compounds differed in that 309 MMV688271 was less selective, inhibiting HsGlck with an IC50 value of 2.58 ± 0.53 µM, a 310 value similar to those found for the parasite enzyme inhibition. Neither Pathogen Box 311 compounds were toxic to Naegleria at 10 µM, but given their IC50 values, this was not 312 surprising (data not shown). 313
From the TbHK1 HTS, two distinct scaffolds were identified and pursued for analog 314 development against TbHK1. Ebselen (SID856002) and the structurally similar 315 isobenzothiazolinone (SID 17387000) were identified as potent inhibitors of the 316 trypanosome enzyme and are active against the Plasmodium HK (22). Of the two agents, 317 only ebselen showed inhibition of NfGlck with an IC50 of 0.88 µM, a notably higher 318 concentration than that required to inhibit the other parasite HKs ( Table 2 ). The second 319 scaffold, a benzamidobenzoic acid-based inhibitor of TbHK1 (20), was developed through 320 structure-activity relationship (SAR) optimization against the trypanosome to yield ML205, a 321 potent inhibitor of TbHK1 (23). While this particular compound was not active against the 322 Naegleria enzyme (IC50 > 10 µM), evaluation of related analogs revealed some promising 323
activity. 324
Analogs of ML205 tested in this work included compounds featuring substitution of 325 the bromine atom on the benzoic acid core. One of the best modifications found for 326 inhibition of TbHK1 involved exchange of the bromine atom of ML205 with a phenyl ring to 327 afford SID144241590 with a TbHK1 IC50 = 0.28 µM; however, this analog showed no 328 significant inhibition of NfGlck. Likewise, bromine substitution with a cyclopropyl group 329 (SID162211071), a 3-pyridyl moiety (SID162211077), or mono-fluorinated phenyl groups 330 (SID162211078 and SID162211083) did not generate analogs that inhibited NfGlck, 331
despite showing submicromolar activity in some cases against TbHK1. 332
While mono-fluorination of the phenyl appendage did not impact NfGlck, 333 incorporation of chlorinated phenyl rings was advantageous against this enzyme. The 334 analog bearing a 3-chlorophenyl group (SID162211084) gave moderate NfGlck inhibition 335 (IC50 = 6.5 µM), the 3-chloro-4-fluorophenyl analog (SID162211073) trended with 336 marginally better potency, and the 3,4-dichlorophenyl derivative (SID162211080) showed 337 the most improved potency against NfGlck with an IC50 = 2.9 µM. Alternative phenyl ring 338 substitutions, which included hydroxylation, methyl or methoxy groups, did not afford 339 analogs with appreciable inhibition of NfGlck, although several of these did demonstrate 340 reasonable inhibition of TbHK1. Other analogs that inhibited NfGlck with potency better 341 than 10 µM featured a 4-trifluoromethylphenyl or 4-trifluoromethoxyphenyl group 342 (SID162211070 and SID162211074, respectively) or a 3-nitrophenyl group 343 (SID162211082). Relative to ML205, the data suggest that elaborated phenyl rings in 344 place of the bromine atom help to refine potency against NfGlck, and the specific 345 substitution patterns that are favored are a result of a combination of spatial and electron-346 withdrawing effects. Further, this effort revealed that the structural elements that improve 347
NfGlck inhibition appear to differ from those driving TbHK1 inhibition for this particular 348 structural series as it relates to changes in this region of the scaffold. For instance, analogs 349 with electron-donating substituents on the phenyl ring registered with some TbHK1 350 inhibition but did not do the same for NfGlck. Alternatively, analogs with more electron-351 deficient phenyl rings appended to the core favored NfGlck inhibition and not TbHK1. As a thermophilic free-living amoeba, N. fowleri is found world-wide in or nearby warm 355 freshwater. In the freshwater habitat, free glucose in the water column is likely limited thus 356 raising the possibility that NfGlck has only a limited role in parasite metabolism in this 357 environment. However, the amoeboid trophozoite feeds on a variety of prey in the water 358 including bacteria, fungi, and other protists, which may generate substrates for NfGlck. The 359 sediment at the bottom of freshwater sources is different, with free sugars including glucose 360
(1.1 mg/g dry weight) characterized in lake sediment samples (24, 25) . Carbohydrates have 361 also been characterized from lake surface mud samples, with glucose found at 13-191 362 mg/kg dry weight (26). These findings suggest that NfGlck may play a role in metabolism 363 of nutrients acquired from the environment through either predation or directly from the 364
sediment. 365
What role could NfGlck play during human infection? The process is usually initiated 366 following forceful introduction of water contaminated with trophozoites into the nasal cavity. 367
The presence of the trophozoites induces the host to secrete mucus, a response that 368 serves as a barrier to invasion of the nearby tissue (27). The mucus contains an 369 abundance of glycoproteins (including mucins), which compose the majority of its dry 370 weight (28). To overcome this obstacle, the parasites release enzymes including 371 glycosidases that degrade the mucin glycan components, potentially liberating substrates 372
for NfGlck while aiding the parasite in accessing underlying tissue for ultimate invasion of 373 the brain (29). 374
Degradation of host tissues during invasion provides access to glucose and glucose-375 bearing host macromolecules. As the parasite attacks the host cribriform plate, glucose 376 availability is presumably enhanced once sufficient tissue damage has occurred to allow 377 access to host blood, which has glucose levels that are maintained at ~5 mM. The brain 378 infection that follows exposes the parasite to lower (though still abundant) glucose 379 concentrations and the presence of parasites has been implicated in reducing the overall 380 CSF glucose levels (5). 381
Whether NfGlck plays a central role in glucose catabolism in the diverse 382 environments in which the parasite can reside remains to be determined. However, 383 because the enzyme also provides substrate to the pentose phosphate pathway (PPP) for 384 the generation of sugar nucleotides, the activity is likely indispensable, a possibility that 385 awaits the development of suitable molecular tools for genetic ablation of the enzyme 386 activity in vivo. Nevertheless, the position of the enzyme at the head of glycolysis and the 387 PPP suggests that interfering with its activity could yield potent anti-parasitic compounds, 388 and the differences in sequence and structure of NfGlck and HsGlck suggest inhibitor 389 specificity could be established. Here, we have identified a number of enzyme inhibitors 390 but none impaired parasite growth at the levels tested (typically 10 µM). This may be for 391 various different reasons, including abundant substrate competitor molecules in the 392 cytoplasm and insufficient access to the target in the cell. It is likely that much more potent 393 inhibitors are required to see inhibition of parasite growth. 394
The NfGlck structure is highly similar to that of TcGlck. The T. cruzi enzyme was 395 noted for having a structure consistent with that described for E. coli glucokinase (EcGlck), 396 a group A Glck, which is a member of the group A ribokinase enzymes (19) . Like other 397 group A enzymes, NfGlck was limited to using ATP as a phosphoryl donor. However, 398 kinetic differences between NfGlck and TcGlck raise the possibility that the Naegleria 399 enzyme is an atypical group A member. This is primarily based on the observation that 400
NfGlck, which can use glucose, glucosamine, or fructose as a substrate, lacks the glucose-401 limited substrate specificity that is a hallmark of group A enzymes. NfGlck and TcGlck also 402 have distinct kinetic properties (7) . NfGlck has an affinity for glucose that is ~23-fold higher 403 than TcGlck, perhaps explained by the additional hydrogen bonds provided by NfGlck 404
His231 with the 1-and 2-hydroxyl groups of glucose, which are not present in TcGlck 405
where the equivalent residue is a Ser (Fig. 5A and B) . Additionally, ADP inhibited NfGlck at 406 much lower concentrations than those required for TcGlck inhibition (7) . 407
The finding that NfGlck requires ATP for activity seems at odds with the presence of 408 a N. fowleri PFK that is PPi-dependent (4). Other pathogenic protists, like the anaerobes 409
Entamoeba histolytica and Trichomonas vaginalis, have PPi-dependent glycolytic enzymes 410 (4, 30), presumably because the alternative phosphoryl group donor allows optimized ATP 411 production under energy-limiting conditions. The metabolic flexibility noted in Naegleria 412 gruberi supports the notion that N. fowleri may have a PPi-dependent PFK in order to 413 support anaerobic fermentation (31) . N. fowleri would likely encounter oxygen-poor 414 environments, particularly when lake sediments are at higher temperatures during summer 415 months. Alternatively, it is possible that an ATP-dependent PFK exists and has not yet 416 been detected. It is known, for example, that some organisms can express either an ATP-417 dependent or PPi-dependent PFK in response to the types of environmental carbon 418 sources available (32). Lastly, in some organisms a PPi-dependent PFK has been 419 postulated to function as both a PFK in glycolysis and a fructose-bisphosphatase in 420 gluconeogenesis (33). This is possible because thermodynamically (and under 421 physiological conditions) PPi can be either consumed or regenerated. A similar role for the 422 N. fowleri PPi-dependent PFK is unlikely, as parasites do not grow in the absence of 423 glucose (Fig. 1 ). This suggests that any G6P generated by the PPi-dependent PFK is 424 insufficient to meet the metabolic demands of the parasite, and supports the notion that 425
NfGlck is essential. Two different buffers with buffering capacity in the range of pH tested were used for the 582 assay: Tris-Cl (pH 7-8.5) and sodium carbonate (pH 9.0-10.5). Reactions were carried out 583 in triplicate, and standard deviations are indicated. 
